Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma
Open Access
Abstract
The last two decades have seen the development of effective therapies, which have saved the lives of a large number of melanoma patients. However, therapeutic options are still limited for patients without BRAF mutations or in relapse from current treatments, and severe side effects often occur during therapy. Thus, additional insights to improve treatment efficacy with the aim to decrease the likelihood of chemoresistance, as well as reducing side effects of current therapies, are required. Natural products offer great opportunities for the discovery of antineoplastic drugs, and still represent a useful source of novel molecules. Among them, essential oils, representing the volatile fraction of aromatic plants, are always being actively investigated by several research groups and show promising biological activities for their use as complementary or alternative medicine for several diseases, including cancer. In this review, we focused on studies reporting the mechanism through which essential oils exert antitumor action in preclinical wild type or mutant BRAF melanoma models. We also discussed the latest use of essential oils in improving cancer patients’ quality of life. As evidenced by the many studies listed in this review, through their effect on apoptosis and tumor progression-associated properties, essential oils can therefore be considered as potential natural pharmaceutical resources for cancer management.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (DDB, IG 18560)
- Sapienza Università di Roma (RR, prot. RM11916B8876093E, RR, prot. RM118164361B425B)
- Progetti di Rilevante Interesse Nazionale (RR, prot. 2017JL8SRX)
- IRCCS Istituto Nazionale Tumori Regina Elena (MDM, Ricerca Corrente 2018-2019)
This publication has 266 references indexed in Scilit:
- Cinnamomum cassia Essential Oil Inhibits α-MSH-Induced Melanin Production and Oxidative Stress in Murine B16 Melanoma CellsInternational Journal of Molecular Sciences, 2013
- 13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cellsOncology Letters, 2013
- Dual Bioactivities of Essential Oil Extracted from the Leaves of Artemisia argyi as an Antimelanogenic versus Antioxidant Agent and Chemical Composition Analysis by GC/MSInternational Journal of Molecular Sciences, 2012
- Antiproliferative and Molecular Mechanism of Eugenol-Induced Apoptosis in Cancer CellsMolecules, 2012
- Inhibition of Melanogenesis Versus Antioxidant Properties of Essential Oil Extracted from Leaves of Vitex negundo Linn and Chemical Composition Analysis by GC-MSMolecules, 2012
- Thujone‐Rich Fraction of Thuja occidentalis Demonstrates Major Anti‐Cancer Potentials: Evidences from In Vitro Studies on A375 CellsEvidence-Based Complementary and Alternative Medicine, 2011
- A Phase 2a Study of Topical Perillyl Alcohol Cream for Chemoprevention of Skin CancerCancer Prevention Research, 2010
- Essential oils of Salvia bracteata and Salvia rubifolia from Lebanon: Chemical composition, antimicrobial activity and inhibitory effect on human melanoma cellsJournal of Ethnopharmacology, 2009
- Cooling skin cancer: menthol inhibits melanoma growth. Focus on “TRPM8 activation suppresses cellular viability in human melanoma”American Journal of Physiology-Cell Physiology, 2008
- Characterization of thimet oligopeptidase and neurolysin activities in B16F10-Nex2 tumor cells and their involvement in angiogenesis and tumor growthMolecular Cancer, 2007